[Federal Register Volume 66, Number 205 (Tuesday, October 23, 2001)]
[Notices]
[Page 53589]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-26674]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Application Concerning Method of Inhibiting 
Side Effects of Pharmaceutical Compositions Containing Amphiphilic 
Vehicles or Drug Carrier Molecules

AGENCY: U.S. Army Medical Research and Materiel Command, DOD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the 
availability for licensing of U.S. Patent Application No. 09/183,375 
entitled ``Method of Inhibiting Side Effects of Pharmaceutical 
Compositions Containing Amphiphilic Vehicles or Drug Carrier 
Molecules'' filed October 30, 1998. Foreign rights are also available 
(PCT/US98/23280). This patent has been assigned to the United States 
Government as represented by the Secretary of the Army.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, Maryland 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664. Both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: A method is provided for inhibiting or 
preventing toxicity and other unwanted effects (a) caused by solvents 
for pharmaceuticals which solvents or emulsifier contain amphiphilic 
molecules such as polyethoxylated oils or a derivative thereof, or (b) 
caused by a drug in a vehicle containing amphiphilic molecules such as 
phospholipids or derivative thereof, employing a complement inhibitor, 
and pharmaceutical compositions including a drug, solvent, or carrier 
containing amphiphilic molecules or derivatives thereof, and a 
complement inhibitor are also provided.

Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 01-26674 Filed 10-22-01; 8:45 am]
BILLING CODE 3710-08-M